Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insulin fast-dissolving film for intranasal delivery via olfactory region, a promising approach for the treatment of anosmia in COVID-19 patients: Design, in-vitro characterization and clinical evaluation
Soad A. Mohamad, Ahmed M. Badawi, Heba F. Mansour
International Journal of Pharmaceutics (2021) Vol. 601, pp. 120600-120600
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics
Albert Leng, Manuj Shah, Syed A. Ahmad, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 816-816
Open Access | Times Cited: 116
ESCMID rapid guidelines for assessment and management of long COVID
Dana Yelin, Charalampos D. Moschopoulos, Ili Margalit, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 7, pp. 955-972
Open Access | Times Cited: 112
Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments
Raziyeh Najafloo, Jila Majidi, Alimohamad Asghari, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 20, pp. 3795-3805
Closed Access | Times Cited: 87
Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review
Elnaz Khani, Sajad Khiali, Samineh Beheshtirouy, et al.
European Journal of Pharmacology (2021) Vol. 912, pp. 174582-174582
Open Access | Times Cited: 59
Untangling Mucosal Drug Delivery: Engineering, Designing, and Testing Nanoparticles to Overcome the Mucus Barrier
Jeffrey Watchorn, Aaron J. Clasky, Gayatri Prakash, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 8, Iss. 4, pp. 1396-1426
Closed Access | Times Cited: 52
Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs
Andrew Lofts, Fahed Abu-Hijleh, Nicolette Rigg, et al.
CNS Drugs (2022) Vol. 36, Iss. 7, pp. 739-770
Open Access | Times Cited: 49
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
Lisa O’Byrne, Katie E Webster, Samuel MacKeith, et al.
Cochrane library (2021) Vol. 2021, Iss. 8
Open Access | Times Cited: 46
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
Lisa O’Byrne, Katie E Webster, Samuel MacKeith, et al.
Cochrane library (2022) Vol. 2022, Iss. 9
Open Access | Times Cited: 33
Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
Katie E Webster, Lisa O’Byrne, Samuel MacKeith, et al.
Cochrane library (2021) Vol. 2021, Iss. 8
Open Access | Times Cited: 33
A Comprehensive Review of COVID-19-Related Olfactory Deficiency: Unraveling Associations with Neurocognitive Disorders and Magnetic Resonance Imaging Findings
Ludovica Simonini, Francesca Frijia, Lamia Ait‐Ali, et al.
Diagnostics (2024) Vol. 14, Iss. 4, pp. 359-359
Open Access | Times Cited: 5
Comparison Between Intranasal Insulin Films Alone and Combined Intranasal Insulin Plus Steroid Films for Post Viral Olfactory Dysfunction
Khalaf Hamead, Mostafa Ismail Ahmed, Abdel rahim Ahmed abdel karim, et al.
Indian Journal of Otolaryngology and Head & Neck Surgery (2025) Vol. 77, Iss. 3, pp. 1230-1237
Closed Access
Post COVID-19 and Long COVID Symptoms in Otorhinolaryngology—A Narrative Review
Orlando Guntinas‐Lichius, Thomas Bitter, Robert P. Takes, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 506-506
Open Access
Intranasal Insulin and Budesonide Combination Films for Treatment of Anosmia: Randomized Clinical Trial
Mostafa Ismail, Abdelrahim A. Abdelkarim, Khalaf Hamead, et al.
Research Square (Research Square) (2025)
Closed Access
The nasal route for nose-to-brain drug delivery: advanced nasal formulations for CNS disorders
Paraskevi Papakyriakopoulou, Georgia Valsami
Expert Opinion on Drug Delivery (2025)
Closed Access
Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
Katie E Webster, Lisa O’Byrne, Samuel MacKeith, et al.
Cochrane library (2022) Vol. 2022, Iss. 9
Open Access | Times Cited: 19
The Potential of Films as Transmucosal Drug Delivery Systems
Ana Clara Wada de Carvalho, Natália Floriano Paiva, Isabella Kriunas Demonari, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2583-2583
Open Access | Times Cited: 11
Post-COVID-19 Anosmia and Therapies: Stay Tuned for New Drugs to Sniff Out
Gabriele Riccardi, Giovanni Francesco Niccolini, Mario Giuseppe Bellizzi, et al.
Diseases (2023) Vol. 11, Iss. 2, pp. 79-79
Open Access | Times Cited: 10
Supramolecular approach to the design of nanocarriers for antidiabetic drugs: targeted patient-friendly therapy
Л. А. Васильева, Gulnara A. Gaynanova, E. A. Romanova, et al.
Russian Chemical Reviews (2024) Vol. 93, Iss. 11, pp. RCR5150-RCR5150
Closed Access | Times Cited: 3
Mechanism and treatment of olfactory dysfunction caused by coronavirus disease 2019
Bian Hu, Mengdan Gong, Yizhen Xiang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Therapeutic options of post-COVID-19 related olfactory dysfunction: a systematic review and meta-analysis
V. Asvapoositkul, J Samuthpongtorn, Songklot Aeumjaturapat, et al.
Rhinology Journal (2022)
Open Access | Times Cited: 12
The Potential of Corchorus olitorius Seeds Buccal Films for Treatment of Recurrent Minor Aphthous Ulcerations in Human Volunteers
Nourhan Hisham Shady, Abdullah H. Altemani, Faisal H. Altemani, et al.
Molecules (2022) Vol. 27, Iss. 20, pp. 7020-7020
Open Access | Times Cited: 12
Intranasal Insulin for the Treatment of Persistent Post‐COVID‐19 Olfactory Dysfunction
Giancarlo Bonotto Cherobin, Roberto Eustáquio Santos Guimarães, Márcia C. de Paula Gomes, et al.
Otolaryngology (2023) Vol. 169, Iss. 3, pp. 710-715
Closed Access | Times Cited: 6
Intranasal insulin for COVID-19-related smell loss
D. Daniel, Loyola-Nieto Paula, Brenner-Muslera Eduardo, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 281, Iss. 1, pp. 201-205
Closed Access | Times Cited: 6
Management of Anosmia in COVID-19: A Comprehensive Review
Khushi Khurana, C. Singh
Cureus (2022)
Open Access | Times Cited: 8
Treatment of COVID-19 Associated Olfactory Dysfunction: A Systematic Review
S.C. Bischoff, Maximiliaan Moyaert, Marnick Clijsters, et al.
Current Allergy and Asthma Reports (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top